Your browser doesn't support javascript.
loading
Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT.
Li, Siqi; Wang, Hongrong; Wang, Guanyun; Lu, Xia; Yang, Jigang.
Afiliação
  • Li S; From the Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China.
  • Wang H; Department of Nuclear Medicine, Beijing Boren Hospital, Beijing, China.
  • Wang G; From the Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China.
  • Lu X; From the Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China.
  • Yang J; From the Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China.
Clin Nucl Med ; 48(5): 445-447, 2023 May 01.
Article em En | MEDLINE | ID: mdl-36716490
ABSTRACT
ABSTRACT 18 F-FDG PET/CT was performed to evaluate possible recurrent B-cell lymphoblastic lymphoma in a 34-year-old man. The images showed multiple foci of increased activity in the nerve root and peripheral nerve. A biopsy confirmed the diagnosis of neurolymphomatosis. After receiving chemotherapy, PET/CT showed progressive disease. The patient subsequently received the CD-19 chimeric antigen receptor T-cell therapy. A follow-up PET/CT acquired 30 days after chimeric antigen receptor T-cell therapy revealed no abnormal FDG activity.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Receptores de Antígenos Quiméricos / Neurolinfomatose Limite: Adult / Humans / Male Idioma: En Revista: Clin Nucl Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Receptores de Antígenos Quiméricos / Neurolinfomatose Limite: Adult / Humans / Male Idioma: En Revista: Clin Nucl Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China